Bristol-Myers Squibb (BMY)
NYSE: BMY
· Real-Time Price · USD
46.26
-1.28 (-2.69%)
At close: Sep 12, 2025, 3:45 PM
Pomalyst Imnovid Revenue
History
Quarter | Value | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 708M | 50M | +7.60% |
Mar 31, 2025 | 658M | -681M | -50.86% |
Dec 31, 2024 | 1.34B | -73M | -5.17% |
Sep 30, 2024 | 1.41B | 59M | +4.36% |
Jun 30, 2024 | 1.35B | -316M | -18.93% |
Mar 31, 2024 | 1.67B | 1.1B | +194.88% |
Dec 31, 2023 | 566M | -13M | -2.25% |
Sep 30, 2023 | 579M | -6M | -1.03% |
Jun 30, 2023 | 585M | 77M | +15.16% |
Mar 31, 2023 | 508M | -60M | -10.56% |
Dec 31, 2022 | 568M | 45M | +8.60% |
Sep 30, 2022 | 523M | 457M | +692.42% |
Jun 30, 2022 | 66M | n/a | n/a |
Mar 31, 2022 | n/a | n/a | n/a |
Dec 31, 2021 | n/a | n/a | n/a |
Sep 30, 2021 | n/a | n/a | n/a |
Jun 30, 2021 | n/a | n/a | n/a |
Mar 31, 2021 | n/a | n/a | n/a |
Dec 31, 2020 | n/a | n/a | n/a |
Sep 30, 2020 | n/a | n/a | n/a |
Jun 30, 2020 | n/a | n/a | n/a |
Mar 31, 2020 | n/a | n/a | n/a |
Dec 31, 2019 | n/a | n/a | n/a |
Sep 30, 2019 | n/a | n/a | n/a |
Jun 30, 2019 | n/a | n/a | n/a |
Mar 31, 2019 | n/a | n/a | n/a |
Dec 31, 2018 | n/a | n/a | n/a |
Sep 30, 2018 | n/a | n/a | n/a |
Jun 30, 2018 | n/a | n/a | n/a |
Mar 31, 2018 | n/a | n/a | n/a |
Dec 31, 2017 | n/a | n/a | n/a |
Sep 30, 2017 | n/a | n/a | n/a |
Jun 30, 2017 | n/a | n/a | n/a |
Mar 31, 2017 | n/a | n/a | n/a |
Dec 31, 2016 | n/a | n/a | n/a |
Sep 30, 2016 | n/a | n/a | n/a |
Jun 30, 2016 | n/a | n/a | n/a |
Mar 31, 2016 | n/a | n/a | n/a |
Dec 31, 2015 | n/a | n/a | n/a |
Sep 30, 2015 | n/a | n/a | n/a |
Jun 30, 2015 | n/a | n/a | n/a |
Mar 31, 2015 | n/a | n/a | n/a |
Dec 31, 2014 | n/a | n/a | n/a |
Sep 30, 2014 | n/a | n/a | n/a |
Jun 30, 2014 | n/a | n/a | n/a |
Mar 31, 2014 | n/a | n/a | n/a |
Dec 31, 2013 | n/a | n/a | n/a |
Sep 30, 2013 | n/a | n/a | n/a |
Jun 30, 2013 | n/a | n/a | n/a |
Mar 31, 2013 | n/a | n/a | n/a |